Annual report pursuant to Section 13 and 15(d)

Stock Based Compensation (Tables)

v3.22.1
Stock Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2021
Stock Based Compensation  
Summary of Company's Stock Options
The following is a summary of the Company’s stock options as of December 31, 2021 and the stock option activity from January 1, 2019 through December 31, 2021:
 
 
  
Number of Options
 
  
Weighted Average
Grant Date Fair
Value per Option
(Amount)
 
  
Weighted
Average Exercise
Price (Amount)
 
  
Weighted Average
Remaining Contractual
Term (Years)
 
Balance, December 31, 2018
  
 
414,434
 
 
$
15.80
 
 
$
141.53
 
 
 
9.3
 
Granted
  
 
 52,083
 
 
 
 15.91
 
 
 
 141.53
 
 
 
 
 
Exercised
  
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
 
 
Forfeited
  
 
 (67,366
) 
 
 
 15.80
 
 
 
 141.53
 
 
 
 
 
Expired
  
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, December 31, 2019
  
 
399,151
 
 
$
15.82
 
 
 
141.53
 
 
 
8.4
 
Granted
  
 
 64,064
 
 
 
 13.50
 
 
 
 141.53
 
 
 
 
 
Exercised
  
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
 
 
Forfeited
  
 
 (30,715
) 
 
 
 15.80
 
 
 
 141.53
 
 
 
 
 
Expired
  
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, December 31, 2020
  
 
432,500
 
 
$
15.45
 
 
$
141.53
 
 
 
7.7
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Granted
  
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
 
 
Exercised
  
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
 
 
Forfeited
  
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
 
 
Expired
  
 
—  
 
 
 
—  
 
 
 
—  
 
 
 
 
 
Cancelled
  
 
 (432,500
) 
 
 
 (15.45
) 
 
 
 (141.53
) 
 
 
(7.7
) 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, December 31, 2021
  
 
—  
 
 
$
—  
 
 
$
—  
 
 
 
—  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Summary of Share-based Compensation Expense
The following is a summary of the Company’s
share
-
based
compensation expense as of December 31, 2021 and 2020:
 
(in ‘000)
  
December 31, 2021
 
  
December 31, 2020
 
Total Stock Compensation Expense
  
$
 4,564
 
  
$
 1,161
 
Unrecognized Compensation Cost
  
 
 —
  
 
  
 
 3,416
 
Remaining recognition period (in years)
  
 
—  
 
  
 
 2.7
 
Summary of Company's Exercisable Stock Options
The following is a summary of the Company’s exercisable stock options as of December 31, 2021 and 2020:
 
 
  
December 31, 2021
 
  
December 31, 2020
 
Range of Exercise Prices
  
 
 —
  
 
  
$
80.87 -$202.18
 
Number
  
 
 —
  
 
  
 
 153,898
 
Weighted Average Remaining Contractual Term (in years)
  
 
—  
 
  
 
 7.3
 
Weighted Average Exercise Price
  
$
 —
  
 
  
$
 141.53